Abstract
Aims This study evaluates the risk of endometrial carcinoma in postmenopausal women presenting with bleeding using an ultrasound-based risk scoring system. It aims to integrate imaging parameters and clinical variables for improved differentiation between benign and malignant endometrial conditions.
Methods A prospective analysis was conducted on postmenopausal women presenting with bleeding per vagina. Clinical variables including age, parity, BMI, hypertension, and diabetes were combined with ultrasound findings such as endometrial thickness, echogenicity, endo-myometrial interface, vascular patterns and Doppler scores. A comprehensive scoring system, based on International Endometrial Tumor Analysis (IETA) terminology, was employed to stratify patients’ risk levels. Diagnostic accuracy was determined by comparing the scoring system outcomes with histopathological findings.
Results The ultrasound-based scoring system demonstrated significant diagnostic accuracy in differentiating between benign and malignant endometrial pathologies. Endometrial thickness greater than 4 mm, heterogeneous echogenicity, irregular endo-myometrial interface and increase vascular flow were identified as strong predictors of malignancy. The model achieved a high sensitivity and specificity, providing a non-invasive yet reliable tool for risk stratification in clinical settings. The findings emphasize the potential of an integrated ultrasound-based scoring system in guiding clinical decisions for postmenopausal women with bleeding.
Conclusion We concluded that by incorporating both clinical and imaging parameters improves diagnostic accuracy, minimizes unnecessary invasive procedures, and aids in timely intervention.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Ethics Committee, J.N Medical College, Aligarh Muslim University
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
